GB0805356D0 - Vaccine adjuvant composition - Google Patents

Vaccine adjuvant composition

Info

Publication number
GB0805356D0
GB0805356D0 GB0805356A GB0805356A GB0805356D0 GB 0805356 D0 GB0805356 D0 GB 0805356D0 GB 0805356 A GB0805356 A GB 0805356A GB 0805356 A GB0805356 A GB 0805356A GB 0805356 D0 GB0805356 D0 GB 0805356D0
Authority
GB
United Kingdom
Prior art keywords
adjuvant composition
vaccine adjuvant
vaccine
composition
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0805356A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GB0805356A priority Critical patent/GB0805356D0/en
Publication of GB0805356D0 publication Critical patent/GB0805356D0/en
Priority to PCT/GB2009/000788 priority patent/WO2009118523A1/en
Ceased legal-status Critical Current

Links

GB0805356A 2008-03-25 2008-03-25 Vaccine adjuvant composition Ceased GB0805356D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0805356A GB0805356D0 (en) 2008-03-25 2008-03-25 Vaccine adjuvant composition
PCT/GB2009/000788 WO2009118523A1 (en) 2008-03-25 2009-03-25 Adjuvant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0805356A GB0805356D0 (en) 2008-03-25 2008-03-25 Vaccine adjuvant composition

Publications (1)

Publication Number Publication Date
GB0805356D0 true GB0805356D0 (en) 2008-04-30

Family

ID=39386659

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0805356A Ceased GB0805356D0 (en) 2008-03-25 2008-03-25 Vaccine adjuvant composition

Country Status (2)

Country Link
GB (1) GB0805356D0 (en)
WO (1) WO2009118523A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9603919B2 (en) 2009-03-31 2017-03-28 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
MX342405B (en) 2010-06-03 2016-09-28 Pharmacyclics Inc The use of inhibitors of bruton's tyrosine kinase (btk).
AU2013293087B2 (en) 2012-07-24 2017-08-31 Pharmacyclics Llc Mutations associated with resistance to inhibitors of Bruton's tyrosine kinase (BTK)
KR20150080592A (en) 2012-11-02 2015-07-09 파마시클릭스, 인코포레이티드 Tec family kinase inhibitor adjuvant therapy
WO2015143400A1 (en) 2014-03-20 2015-09-24 Pharmacyclics, Inc. Phospholipase c gamma 2 and resistance associated mutations
WO2017218819A1 (en) 2016-06-17 2017-12-21 Merial, Inc. Novel immunogenic formulations comprising linear or branched polyacrylic acid polymer adjuvants
WO2023120535A1 (en) * 2021-12-20 2023-06-29 東興薬品工業株式会社 Vaccine adjuvant agent containing polyacrylic acid polymer and use of same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775601B1 (en) * 1998-03-03 2001-09-21 Merial Sas RECOMBINANT LIVING VACCINES AND ADJUVANTS
FR2776928B1 (en) * 1998-04-03 2000-06-23 Merial Sas ADJUVATED DNA VACCINES
US20030104008A1 (en) * 2001-04-06 2003-06-05 Loosmore Sheena May Recombinant vaccine against west nile virus
US7862821B2 (en) * 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
DE602007010127D1 (en) * 2006-06-01 2010-12-09 Statens Seruminstitut Hiv-impfstoff

Also Published As

Publication number Publication date
WO2009118523A1 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
HK1211870A1 (en) Novel adjuvant compositions
HK1159485A1 (en) Vaccine composition containing synthetic adjuvant
ZA201101481B (en) Vaccine
EP2344522A4 (en) Combination adjuvant formulation
HRP20151124T1 (en) Vaccine
IL208660A0 (en) Coccididosis vaccines
GB0810869D0 (en) Vaccine adjuvant composition
GB0822001D0 (en) Vaccine
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
GB0805356D0 (en) Vaccine adjuvant composition
GB0816284D0 (en) Vaccine
EP2498815A4 (en) Vaccine composition
EP2252326A4 (en) Vaccine compositions
GB0816447D0 (en) Vaccine
EP2254593A4 (en) Immunogenic influenza composition
GB0801326D0 (en) Vaccines
EP2337847A4 (en) Vaccine adjuvants
GB0801122D0 (en) Vaccine composition
GB0802326D0 (en) Vaccine Composition
GB0820404D0 (en) Vaccine compositions
GB0702363D0 (en) Vaccine composition
GB0809781D0 (en) Vaccine
GB0820478D0 (en) Vaccine
GB0810914D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)